MoleMap
MoleMap is a New Zealand-founded private medical practice specializing in skin cancer detection and monitoring via a triple-check model combining nurse melanographers, proprietary AI, and dermatologist diagnosis, serving high-risk individuals, corporate workplaces, and GP-referred patients across New Zealand and Australia.
- Company typePrivate
- Founded1996
- HeadquartersAuckland, New Zealand
- Headcount51–100
- GTM typeB2C
- OfferingServices
What MoleMap does
MoleMap is a New Zealand-founded private medical practice company specializing in skin cancer detection, proactive monitoring, and diagnosis, established in 1996 and headquartered in Auckland with operations across New Zealand and Australia. The company operates a multi-tiered clinical service platform — Full Body MoleMap (comprehensive head-to-toe skin check with full body photography and ongoing monitoring, ~50 minutes), SkinCheck+ (mid-tier check with full body imaging, ~20-30 minutes), and SkinCheck (point-in-time assessment, ~15-20 minutes) — all delivered through a proprietary "triple-check" model combining registered-nurse melanographers, a custom-built AI diagnostic tool cross-referenced against a 30-year image database of 13M+ moles, and accredited dermatologist diagnosis. Services extend to skin cancer treatment (topical therapy, cryotherapy, surgery), workplace onsite screening programs for enterprise customers, and a fast-tracked GP referral pathway.
The company generates revenue through pay-as-you-go professional service fees across its service tiers, supplemented by enterprise workplace contracts and insurer-affiliated treatment billing (Southern Cross Affiliated Provider at select clinics). Go-to-market combines direct consumer acquisition via online booking and phone, enterprise field sales for workplace programs, and channel partnerships with GPs and healthcare providers. MoleMap serves three primary segments: high-risk individuals requiring regular surveillance, corporate workplaces with outdoor or dispersed workforces, and GPs/healthcare providers seeking specialist diagnostic support. The company is privately held with 51-100 employees, has no disclosed external funding rounds beyond a small 2016 Callaghan Innovation grant, and is led by CEO Michelle Aquilina with Chief Medical Officer Dr Lorna Claydon overseeing clinical operations.
MoleMap firmographics
Firmographics- Name
- MoleMap
- Legal name
- MoleMap New Zealand
- Website
- https://molemap.co.nz
- Company type
- Private
- Founded year
- 1996
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- MoleMap is a New Zealand-founded private medical practice specializing in skin cancer detection and monitoring via a triple-check model combining nurse melanographers, proprietary AI, and dermatologist diagnosis, serving high-risk individuals, corporate workplaces, and GP-referred patients across New Zealand and Australia.
- Ownership category
- akta.pro rank
MoleMap industry classification
Industry- Product category
- Skin Cancer Detection Services
- NAICS
- Medical and Diagnostic Laboratories (62151)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)
- akta.pro primary industry
- General & Medical Dermatology (HLAKACAA)
- akta.pro secondary industries
- Dermatology Telemedicine Platforms (HLALAGAA), Procedural Dermatology (Office-Based Surgery) (HLAKACAG)
Keywords
Where MoleMap is headquartered
LocationHeadquarters
- HQ city
- Auckland
- HQ country
- New Zealand
- HQ region
- Oceania
Offices19 records
Markets served
MoleMap business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales
Revenue model
- Skin Check Services: Professional skin examination services including SkinCheck, SkinCheck+, and Full Body MoleMap. Services include head-to-toe skin checks by melanographers, dermatologist diagnosis, and ongoing monitoring. Pricing varies by service tier and includes consultation, imaging, and specialist review.
- Skin Cancer Treatment: Treatment services including surgery, topical therapy, and cryotherapy delivered by skin cancer doctors within the clinic network. Southern Cross Affiliated Provider for eligible treatment services at select clinics.
- Workplace Skin Check Programs: Corporate health programs delivered onsite at workplaces or via voucher programs for employees. Easy to implement for hybrid and dispersed workforces.
- GP Referral Services: Fast-tracked dermatologist diagnosis for referred patients with comprehensive reports for co-management of patient care.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Full Body MoleMap - Most comprehensive monitoring service |
| Other | Pay-as-you-go | SkinCheck+ - Point-in-time check with full body imaging |
| Other | Pay-as-you-go | SkinCheck - Basic point-in-time skin check |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels5 records
MoleMap product offering
Product offeringCore offering
MoleMap operates a network of skin cancer detection and monitoring clinics across New Zealand, delivering professional skin examination services through a triple-check model that combines melanographer-led screening, AI-assisted diagnostic analysis against a 30-year image database, and accredited dermatologist diagnosis. The company offers tiered skin check services (Full Body MoleMap, SkinCheck+, and SkinCheck), in-clinic skin cancer treatments, workplace screening programs, and a GP referral pathway for fast-tracked specialist diagnosis.
Product overview
MoleMap is a comprehensive skin cancer detection, diagnosis, and monitoring service provider operating across New Zealand. The core offering is a multi-tiered platform of skin check services: Full Body MoleMap (flagship comprehensive monitoring), SkinCheck+ (with full body imaging), and SkinCheck (point-in-time assessment). All services include melanographer-led examinations, AI-assisted analysis against a 30-year image database, and dermatologist diagnosis. The platform extends to skin cancer treatment, workplace screening programs, and GP referral pathways. The 'triple check' model combines melanographer expertise, AI diagnostic technology, and dermatologist review for enhanced accuracy.
Differentiator
Problem solved
Functional benefit
Products and services
- Full Body MoleMap
Quantifiable outcome
- 95% of melanomas are treatable if detected very early
- +1 more outcomes
Companies that use MoleMap
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles3 records
MoleMap technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
AI capability4 records
Feature4 records
MoleMap partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Eau Thermale AvènecoreMoleMap partnered with leading skincare brand Eau Thermale Avène in December 2024 to combine MoleMap's expert skin checks with Avène's 30+ years of dermatological expertise in suncare. The collaboration includes joint events such as skin checks at Bondi Beach, sunscreen sampling, and consumer education on skin cancer prevention and detection. Both companies share a commitment to fighting skin cancer in New Zealand through education, detection, and prevention.
Scale indicators5 records
Recent moves5 records
Expansion highlights5 records
MoleMap competitors and assessment
Company assessmentDirect peers
- MoleSafe: MoleSafe offers mole mapping and skin surveillance using dermoscopic imaging and dermatologist review, directly overlapping MoleMap's Full Body MoleMap service in NZ/AU. Highly comparable in clinical workflow, technology stack (total body photography + dermoscopy), and target customer segments.
- MoleCare Skin Cancer Clinic: New Zealand-based skin cancer clinic network providing skin checks, dermoscopy, and skin cancer treatment. Direct overlap with MoleMap on service mix (screening + treatment), geography (NZ), and target audience (high-risk individuals).
Emerging players
- SkinVision: SkinVision provides AI-powered smartphone-based skin cancer risk assessment with dermatologist review. Compares to MoleMap on AI dermatology capability and direct-to-consumer screening intent, though delivered via app rather than in-clinic melanographer visits.
- Skin Analytics: UK-based AI dermatology platform partnering with NHS for melanoma detection using dermoscopic image analysis. Closely comparable AI capability to MoleMap's custom image-database tool, with a health-system distribution model rather than owned clinics.
- First Derm: First Derm is a teledermatology platform offering asynchronous dermatologist review of skin lesion photos. Comparable to MoleMap's melanographer + remote dermatologist workflow, though consumer-app-led rather than clinic-led.
- iDoc24: Teledermatology service providing image-based dermatologist consultations within 24 hours. Overlaps MoleMap's melanographer-captured images → dermatologist-review workflow, focused on consumer-direct skin lesion triage.
Regional players
- National Skin Cancer Centres: Australian network of skin cancer clinics offering full-body skin checks, dermoscopy, and treatment. Closely matches MoleMap's Australia-side offering with a multi-site clinical model in the same target geography.
- Doctor Anywhere: Southeast Asia telehealth platform offering virtual consultations with specialists including dermatologists. Comparable on tele-dermatology delivery model and consumer-pay revenue model, though operating across SEA rather than NZ/AU.
Broad incumbents
- Maple: Canadian telehealth platform providing on-demand access to doctors and specialists, including dermatology consultations. Compares on the telehealth/remote-specialist model MoleMap uses for dermatologist diagnosis, though across a broader primary care scope.
- Teladoc Health: Global telehealth incumbent offering virtual dermatology among other specialties. Compares on tele-dermatology delivery and remote-specialist diagnosis, though at vastly greater scale and as part of a broad virtual care portfolio.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
MoleMap social profiles
Digital presenceMoleMap financial estimates
Financial estimateRevenue estimate
Valuation estimate
MoleMap leadership team
Management profileNumber of profiles
Profiles6 records
MoleMap funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MoleMap M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MoleMap
What does MoleMap do?
MoleMap operates a network of skin cancer detection and monitoring clinics across New Zealand, delivering professional skin examination services through a triple-check model that combines melanographer-led screening, AI-assisted diagnostic analysis against a 30-year image database, and accredited dermatologist diagnosis. The company offers tiered skin check services (Full Body MoleMap, SkinCheck+, and SkinCheck), in-clinic skin cancer treatments, workplace screening programs, and a GP referral pathway for fast-tracked specialist diagnosis.
Is MoleMap a public or private company?
MoleMap is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was MoleMap founded?
MoleMap was founded in 1996. It employs 51 to 100 people.
Where is MoleMap based?
MoleMap is headquartered in Auckland, New Zealand, in the Oceania region.
How does MoleMap make money?
Four revenue lines are on record. Skin Check Services are the primary driver. The others are skin Cancer Treatment, workplace Skin Check Programs and GP Referral Services.
Who are MoleMap's main competitors?
Direct peers on record are MoleSafe and MoleCare Skin Cancer Clinic. Emerging players are SkinVision, Skin Analytics, First Derm and iDoc24. Regional players are National Skin Cancer Centres and Doctor Anywhere. Broad incumbents are Maple and Teladoc Health.
Does MoleMap have an API?
No public API is recorded for MoleMap.
What industry is MoleMap in?
MoleMap's product category is Skin Cancer Detection Services. Its primary akta.pro industry code is HLAKACAA, General & Medical Dermatology, with a secondary code of HLALAGAA, Dermatology Telemedicine Platforms. Its NAICS code is 62151 and its SIC code is 8011.